Allergan (AGN) Shares Pummeled on New Inversion Rules

Shares of Allergan plc (AGN) were trading down -53.55 or -19.29 percent to $224.00 per share in Tuesday's premarket after the Treasury Department announced new steps to curb "inversion" transactions, deals where U.S. companies reincorporate abroad after the purchase of a foreign company. Allergan stock closed at $277.55, up +9.46 or +3.53 percent in Monday's ... READ MORE Read the rest of Allergan (AGN) Shares Pummeled on New Inversion Rules at InvestorGuide.com .